ridostin and Chronic-Disease

ridostin has been researched along with Chronic-Disease* in 2 studies

Trials

1 trial(s) available for ridostin and Chronic-Disease

Article	Year
Chrono- and Immunocorrection of Inflammatory Disorders of Internal Reproductive Organs in Women of Reproductive Age. Bulletin of experimental biology and medicine, 2015, Volume: 159, Issue:1 We compared the effectiveness of immunomodulators used in the treatment of patients with chronic salpingitis and oophoritis with or without changes in succinate dehydrogenase (SDH) activity in blood lymphocytes at incubation with the drug. Diurnal variations in individual reaction of SDH in blood lymphocytes to thymalin or ridostin were revealed. In the groups of women receiving ridostin or thymalin during the reaction of lymphocyte SDH to it, improvement of clinical laboratory and immunological parameters was observed in the majority of the patients and no effect was found in a lesser group of patients than in the groups treated with drugs during the absence of lymphocyte SDH reaction thereto. The timing of the presence of SDH reaction to drugs in the immunocompetent cells makes it possible to set the optimal daily regime of their application and to select a drug that would be most effective in each particular case. Topics: Adolescent; Adult; Anti-Bacterial Agents; Chronic Disease; Combined Modality Therapy; Cytoplasmic Granules; Drug Chronotherapy; Drug Therapy, Combination; Female; Humans; Immunologic Factors; Killer Cells, Natural; L-Lactate Dehydrogenase; Lymphocyte Subsets; Monocytes; Oophoritis; Physical Therapy Modalities; Precision Medicine; RNA, Double-Stranded; RNA, Fungal; Salpingitis; Succinate Dehydrogenase; Thymus Hormones; Treatment Outcome; Vitamins; Young Adult	2015

Article

Year

Chrono- and Immunocorrection of Inflammatory Disorders of Internal Reproductive Organs in Women of Reproductive Age.

Bulletin of experimental biology and medicine, 2015, Volume: 159, Issue:1

We compared the effectiveness of immunomodulators used in the treatment of patients with chronic salpingitis and oophoritis with or without changes in succinate dehydrogenase (SDH) activity in blood lymphocytes at incubation with the drug. Diurnal variations in individual reaction of SDH in blood lymphocytes to thymalin or ridostin were revealed. In the groups of women receiving ridostin or thymalin during the reaction of lymphocyte SDH to it, improvement of clinical laboratory and immunological parameters was observed in the majority of the patients and no effect was found in a lesser group of patients than in the groups treated with drugs during the absence of lymphocyte SDH reaction thereto. The timing of the presence of SDH reaction to drugs in the immunocompetent cells makes it possible to set the optimal daily regime of their application and to select a drug that would be most effective in each particular case.

Topics: Adolescent; Adult; Anti-Bacterial Agents; Chronic Disease; Combined Modality Therapy; Cytoplasmic Granules; Drug Chronotherapy; Drug Therapy, Combination; Female; Humans; Immunologic Factors; Killer Cells, Natural; L-Lactate Dehydrogenase; Lymphocyte Subsets; Monocytes; Oophoritis; Physical Therapy Modalities; Precision Medicine; RNA, Double-Stranded; RNA, Fungal; Salpingitis; Succinate Dehydrogenase; Thymus Hormones; Treatment Outcome; Vitamins; Young Adult

2015

Other Studies

1 other study(ies) available for ridostin and Chronic-Disease

Article	Year
[Experience in the use of present day immunomodulators for prophylaxis of exacerbations of chronic adenoiditis and development of pharyngeal tonsil hypertrophy in poor health children]. Vestnik otorinolaringologii, 2003, Issue:3 Children having frequent acute respiratory infections and chronic adenoiditis were given immunomodulators (ridostin, IRS-19, polyoxidonium). As a result of such prophylaxis, respiratory infections and exacerbations of chronic adenoiditis occurred in poor-health children 2-2.5 times less frequently. Their local immunity and nonspecific resistance improved. Thus, modern immunomodulators can be used in poor-health children with chronic adenoiditis to prevent acute respiratory viral infection and development of pharyngeal tonsil hypertrophy as well as to treat them. Topics: Adenoids; Adjuvants, Immunologic; Child; Child, Preschool; Chronic Disease; Humans; Hypertrophy; Interferon Inducers; Palatine Tonsil; Paranasal Sinus Diseases; Recurrence; RNA, Double-Stranded; RNA, Fungal	2003

Article

Year

[Experience in the use of present day immunomodulators for prophylaxis of exacerbations of chronic adenoiditis and development of pharyngeal tonsil hypertrophy in poor health children].

Vestnik otorinolaringologii, 2003, Issue:3

Children having frequent acute respiratory infections and chronic adenoiditis were given immunomodulators (ridostin, IRS-19, polyoxidonium). As a result of such prophylaxis, respiratory infections and exacerbations of chronic adenoiditis occurred in poor-health children 2-2.5 times less frequently. Their local immunity and nonspecific resistance improved. Thus, modern immunomodulators can be used in poor-health children with chronic adenoiditis to prevent acute respiratory viral infection and development of pharyngeal tonsil hypertrophy as well as to treat them.

Topics: Adenoids; Adjuvants, Immunologic; Child; Child, Preschool; Chronic Disease; Humans; Hypertrophy; Interferon Inducers; Palatine Tonsil; Paranasal Sinus Diseases; Recurrence; RNA, Double-Stranded; RNA, Fungal

2003